Labcorp Holdings Inc.
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and… Read more
Labcorp Holdings Inc. (LH) - Net Assets
Latest net assets as of : MX$- MXN
Based on the latest financial reports, Labcorp Holdings Inc. (LH) has net assets worth MX$- MXN as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (MX$-) and total liabilities (MX$-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | MX$- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Labcorp Holdings Inc. - Net Assets Trend (None–None)
This chart illustrates how Labcorp Holdings Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Labcorp Holdings Inc. (None–None)
The table below shows the annual net assets of Labcorp Holdings Inc. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Labcorp Holdings Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Labcorp Holdings Inc. Competitors by Market Cap
The table below lists competitors of Labcorp Holdings Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CENOVUS ENERGY PFD SR.1
F:CXD0
|
$18.70 Billion |
|
Snap-On Inc
NYSE:SNA
|
$18.72 Billion |
|
Pernod Ricard SA
PINK:PDRDF
|
$18.72 Billion |
|
T. Rowe Price Group Inc
NASDAQ:TROW
|
$18.74 Billion |
|
Formula One Group
PINK:FWONB
|
$18.69 Billion |
|
Principal Financial Group Inc
NASDAQ:PFG
|
$18.68 Billion |
|
Amcor PLC
NYSE:AMCR
|
$18.67 Billion |
|
Burlington Stores Inc
NYSE:BURL
|
$18.67 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Labcorp Holdings Inc.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Labcorp Holdings Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Labcorp Holdings Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Labcorp Holdings Inc.'s net assets metrics with peer companies in the Diagnostics & Research industry.
No peer company data available for comparison.